These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 8783161)

  • 1. Simultaneous purification of influenza haemagglutinin and neuraminidase proteins by immunochromatography.
    Gerentes L; Kessler N; Thomas G; Aymard M
    J Virol Methods; 1996 Apr; 58(1-2):155-65. PubMed ID: 8783161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimation of the neuraminidase content of influenza viruses and split-product vaccines by immunochromatography.
    Tanimoto T; Nakatsu R; Fuke I; Ishikawa T; Ishibashi M; Yamanishi K; Takahashi M; Tamura S
    Vaccine; 2005 Aug; 23(37):4598-609. PubMed ID: 15964668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype.
    Walz L; Kays SK; Zimmer G; von Messling V
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29925654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supplementation of conventional influenza A vaccine with purified viral neuraminidase results in a balanced and broadened immune response.
    Johansson BE; Matthews JT; Kilbourne ED
    Vaccine; 1998; 16(9-10):1009-15. PubMed ID: 9682352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization with dissociated neuraminidase, matrix, and nucleoproteins from influenza A virus eliminates cognate help and antigenic competition.
    Johansson BE; Kilbourne ED
    Virology; 1996 Nov; 225(1):136-44. PubMed ID: 8918540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Supplementation of conventional trivalent influenza vaccine with purified viral N1 and N2 neuraminidases induces a balanced immune response without antigenic competition.
    Johansson BE; Pokorny BA; Tiso VA
    Vaccine; 2002 Feb; 20(11-12):1670-4. PubMed ID: 11858877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VaxArray for hemagglutinin and neuraminidase potency testing of influenza vaccines.
    Kuck LR; Byrne-Nash R; Gillis J; Bueter K; Couzens LK; Eichelberger MC; Rowlen KL
    Vaccine; 2018 May; 36(21):2937-2945. PubMed ID: 29699789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuraminidase activity and specificity of influenza A virus are influenced by haemagglutinin-receptor binding.
    Lai JCC; Karunarathna HMTK; Wong HH; Peiris JSM; Nicholls JM
    Emerg Microbes Infect; 2019; 8(1):327-338. PubMed ID: 30866786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization with influenza A virus hemagglutinin and neuraminidase produced in recombinant baculovirus results in a balanced and broadened immune response superior to conventional vaccine.
    Johansson BE
    Vaccine; 1999 Apr; 17(15-16):2073-80. PubMed ID: 10217609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A sensitive and specific ELISA immunocapture assay for rapid quantitation of influenza A/H3N2 neuraminidase protein.
    Gerentes L; Kessler N; Aymard M
    J Virol Methods; 1998 Aug; 73(2):185-95. PubMed ID: 9766889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Independent and disparate evolution in nature of influenza A virus hemagglutinin and neuraminidase glycoproteins.
    Kilbourne ED; Johansson BE; Grajower B
    Proc Natl Acad Sci U S A; 1990 Jan; 87(2):786-90. PubMed ID: 2300562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced protection against a lethal influenza virus challenge by immunization with both hemagglutinin- and neuraminidase-expressing DNAs.
    Chen Z; Matsuo K; Asanuma H; Takahashi H; Iwasaki T; Suzuki Y; Aizawa C; Kurata T; Tamura S
    Vaccine; 1999 Feb; 17(7-8):653-9. PubMed ID: 10067670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies Directed toward Neuraminidase N1 Control Disease in a Mouse Model of Influenza.
    Job ER; Schotsaert M; Ibañez LI; Smet A; Ysenbaert T; Roose K; Dai M; de Haan CAM; Kleanthous H; Vogel TU; Saelens X
    J Virol; 2018 Feb; 92(4):. PubMed ID: 29167342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunobiological properties of influenza A (H7N9) hemagglutinin and neuraminidase proteins.
    Jiang L; Changsom D; Lerdsamran H; Wiriyarat W; Masamae W; Noisumdaeng P; Jongkaewwattana A; Puthavathana P
    Arch Virol; 2016 Oct; 161(10):2693-704. PubMed ID: 27406044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influenza A viruses possessing type B hemagglutinin and neuraminidase: potential as vaccine components.
    Horimoto T; Iwatsuki-Horimoto K; Hatta M; Kawaoka Y
    Microbes Infect; 2004 May; 6(6):579-83. PubMed ID: 15158192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunity to influenza.
    Schild GC; Oxford JS; Virelizier JL
    Dev Biol Stand; 1975; 28():253-72. PubMed ID: 47824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influenza virus neuraminidase with hemagglutinin activity.
    Laver WG; Colman PM; Webster RG; Hinshaw VS; Air GM
    Virology; 1984 Sep; 137(2):314-23. PubMed ID: 6485252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-administration of certain DNA vaccine combinations expressing different H5N1 influenza virus antigens can be beneficial or detrimental to immune protection.
    Patel A; Gray M; Li Y; Kobasa D; Yao X; Kobinger GP
    Vaccine; 2012 Jan; 30(3):626-36. PubMed ID: 22119588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-Reactive Neuraminidase-Inhibiting Antibodies Elicited by Immunization with Recombinant Neuraminidase Proteins of H5N1 and Pandemic H1N1 Influenza A Viruses.
    Liu WC; Lin CY; Tsou YT; Jan JT; Wu SC
    J Virol; 2015 Jul; 89(14):7224-34. PubMed ID: 25948745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global host immune response: pathogenesis and transcriptional profiling of type A influenza viruses expressing the hemagglutinin and neuraminidase genes from the 1918 pandemic virus.
    Kash JC; Basler CF; García-Sastre A; Carter V; Billharz R; Swayne DE; Przygodzki RM; Taubenberger JK; Katze MG; Tumpey TM
    J Virol; 2004 Sep; 78(17):9499-511. PubMed ID: 15308742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.